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ABSTRACT
Mirtrons, short hairpin pre-microRNA (miRNA)
mimics directly produced by intronic splicing, have
recently been identified and experimentally con-
firmed in invertebrates. While there is evidence to
suggest several mammalian miRNAs have mirtron
origins, this has yet to be experimentally demons-
trated. Here, we characterize the biogenesis of
mammalian mirtrons by ectopic expression of
splicing-dependent mirtron precursors. The
putative mirtrons hsa-miR-877, hsa-miR-1226 and
mmu-miR-1224 were designed as introns within
eGFP. Correct splicing and function of these se-
quences as introns was shown through eGFP fluor-
escence and RT–PCR, while all mirtrons suppressed
perfectly complementary luciferase reporter targets
to levels similar to that of corresponding independ-
ently expressed pre-miRNA controls. Splicing-
deficient mutants and disruption of key steps in
miRNA biogenesis demonstrated that mirtron-
mediated gene knockdown was splicing-dependent,
Drosha-independent and had variable dependence
on RNAi pathway elements following pre-miRNA
formation. The silencing effect of hsa-miR-877 was
further demonstrated to be mediated by the gener-
ation of short anti-sense RNA species expressed
with low abundance. Finally, the mammalian mirtron
hsa-miR-877 was shown to reduce mRNA levels of
an endogenous transcript containing hsa-miR-877
target sites in neuronal SH-SY5Y cells. This work
confirms the mirtron origins of three mammalian
miRNAs and suggests that they are a functional
class of splicing-dependent miRNAs which are
physiologically active.
INTRODUCTION
Mirtrons, which were recently discovered and character-
ized in invertebrates, are novel cellular RNA interference
(RNAi) effectors generated via a non-classical miRNA
pathway (1,2). In canonical miRNA processing, Drosha
initially cleaves mono- or poly-cistronic primary-miRNA
(pri-miRNA) transcripts into precursor-miRNA (pre-
miRNA) hairpins in the nucleus. The recognition sequence
for processing appears to be a hairpin structure with
33-bp stem and terminal loop ﬂanked by un-paired
nucleic acid sequences. The Drosha/DGCR8 microproces-
sor complex recognizes the ﬂanking regions merging into
the base of the stem and cuts the stem–loop 11 nt in to
produce the shortened pre-miRNA (3). In contrast,
mirtrons were identiﬁed in small RNA libraries of inver-
tebrates as small RNA species that clustered at the outer
edge of short introns, with un-paired ﬂanking sequences
immediately adjacent to the splice junctions (1). Based on
these observations splicing, rather than Drosha cleavage,
is expected to be responsible for deﬁning the ends of
the pre-miRNA hairpin, with complementary sequences
at the 50- and 30-ends of the intron allowing hairpin
formation (1,2).
First reported in Drosophila melanogaster and
Caenorhabditis elegans, experimental evidence to support
the existence, splicing dependence and function of mam-
malian mirtrons is lacking. However, several lines of evi-
dence suggest that mammalian mirtrons are likely to be
produced as functional pre-miRNA precursors. Short
RNA species corresponding to predicted mirtrons have
been identiﬁed in mammalian small RNA libraries, some
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of which show cross-species conservation (4). These are
likely to be processed independently of Drosha since the
terminal nucleotides located towards the base of predicted
hairpin stems represent the ﬁrst or last nucleotides of
intronic regions. These putative mirtrons, which lack
extended hairpin features, do not form canonical Drosha
substrates (3,4). Furthermore, ablation of the Drosha/
DGCR8 microprocessor complex has a less severe pheno-
type than Dicer depletion in mouse embryonic stem cells,
suggesting the existence of microprocessor-independent
miRNAs in these cells (5). This was conﬁrmed by deep
sequencing from these two populations of cells, which
reveal a subset of processed miRNAs in DGCR8
silenced cells that are located within referenced short
introns and that are analogous to the mirtrons of D.
melanogaster and C. elegans (1,2,5). However, additional
pleiotropic effects of both Dicer and Drosha may also be
responsible for this phenotype (6). Finally, the observation
that some predicted mirtrons appear restricted to individ-
ual mammalian orders, for example the exclusively
primate miR-1226, implies recent evolutionary origins
and suggests that the mirtron biogenesis of miRNAs
might be a mechanism in which new miRNA species can
be introduced readily into gene regulatory pathways and
subsequently have signiﬁcant involvement in evolutionary
diversiﬁcation (4).
In this study, we demonstrate that mammalian mirtrons
are functional RNAi effectors through the ectopic expres-
sion of mirtron precursors embedded as artiﬁcial introns
within the coding region of eGFP. We show that function-
al mammalian mirtrons are capable of splicing-dependent
silencing, are independent of Drosha processing, while de-
pendence on the remainder of the RNAi pathway is
variable. Moreover, we provide evidence of the functional
activity of mirtrons by showing that hsa-miR-877
(miR-877) is able to reduce mRNA levels of an endogen-
ous transcript containing seed-matched target sites for
miR-877 in dopaminergic SH-SY5Y neuronal cells.
These results provide the ﬁrst experimental veriﬁcation
for the existence of the splicing-dependent mammalian
miRNAs termed mirtrons.
MATERIALS AND METHODS
Constructs
All sequences used can be found in Supplementary
Table S1.
For mirtron constructs, two fragments of eGFP were
ampliﬁed by polymerase chain reaction (PCR) from
pEGFP-C1 (Clontech, CA, USA) with the following pri-
mers (1st set: 50-AGATCCGCTAGCGCTACCGGTC-30
and 50-GTCTACTCGAGAAGACTACTTGAAGAAGA
TGGTGCGC-30; 2nd set: 50-GTCTTCTCGAGAAGACT
TGACGACGGCAACTACAAGA-30 and 50-ATCGAAG
CTTACTTGTACAGCTCGTCCAT-30). The fragments
were digested with restriction enzymes NheI/XhoI and
XhoI/HindIII (NEB, MA, USA), respectively, and ligated
back into the pEGFP-C1 vector, to create an EGFP tran-
script with two BbsI restriction sites between the 50-TCTT
CAAG/GACGACGG-30 exon splice junction to form the
pEGFP-Mirt plasmid. Subsequently, all mirtron inserts
described in this article were made by ligating complemen-
tary primers (Sigma Genosys, UK) with a 50-CAAG
overhang on the sense strand and 50-CGTC on the anti-
sense in to a BbsI-digested pEGFP-Mirt plasmid.
pre-miRNA expression plasmids were designed with
mirtron stem–loops being transcribed of a U6 promoter.
PCR was performed with Pol-III U6 promoter as template
and pre-miRNA as 30 primer as follows: U6F 50-ATCGGG
CCCGTCGACAAGGTCGGGCAGGAAGAGGGCCT-30;
U6R 50-AAAAAA-Antisense-TGGGTCAGG-Sense-GGTG
TTTCGTCCTTTCCACAA-30. PCR products were TA-
cloned into the pGEM-T Easy vector (Promega) to gener-
ate pol-III expressed pre-miRNA plasmids. The miR-877
sponge was created in the same manner but with six con-
secutive FXR2 target sequences for miR-877 incorporated
in replace of the hairpin sequence. Lentiviral constructs
with conditionally expressed Drosha or non-speciﬁc
shRNAs were a kind gift of Dr L. Aagaard.
Pri-miRNA-30-based expression plasmids were synthes-
ized as previously outlined (7). Brieﬂy, complementary
oligonucleotides containing both anti-sense and sense
strands separated by the miR-30 loop were annealed
together and subcloned into the miR-30 pri-miRNA tran-
script under control of the U6 promoter using BfuA1 re-
striction sites. Pri-miRNA-122 constructs were a kind gift
of Dr Abdullah Ely (8).
Target sequences of mirtrons used in the luciferase assay
were synthesized as annealed complementary primers and
ligated into psiCheck2.2 vector (Promega, USA) with
XhoI and NotI restriction sites.
Human exportin-5 was cloned into peGFP-C1 down-
stream of eGFP with BspEI and XhoI, with the start
codon beginning immediately after BspEI to produce
pEGFP-XPO5.
Cell culture, transfections and luciferase assays
HEK-293 cells (ATCC, CRL-1573) and SH-SY5Y cells
(ATCC, CRL-2266) were cultured in DMEM supple-
mented with 10% FCS. For transfection, cells were grown
in 24-well plates to 80% conﬂuence and transfected with
Lipofectamine 2000 (Invitrogen, USA) according to manu-
facturer’s instruction. All mirtron, shRNA and target plas-
mid constructs were transfected at a concentration of
500 ng/ml in HEK-293 cells unless otherwise stated.
HEK-293 cells were harvested 2 days after transfection un-
less stated otherwise and probed for luciferase activity
using dual-luciferase reporter assay system (Promega,
USA) and Wallac-Victor 2 plate reader as per manufac-
turer’s instructions. Ratios of renilla luciferase:ﬁreﬂy
luciferase were obtained and normalized to speciﬁc con-
struct controls utilizing the same promoter. Dominant
negative Drosha expression plasmid was a kind gift from
Dr V. Narry Kim (Seoul University) (9). Dominant
negative Drosha was transfected at a concentration of
500 ng/ml 24 h prior to transfection of experimental con-
structs each at concentrations of 200 ng/ml. Transfection
of mirtrons into SH-SY5Y cells was carried out at 2 mg/ml
and harvesting for protein and RNA carried out 4 days
post-transfection. For conditional expression of shRNAs
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from lenti-viral constructs, cells were grown in the
presence of 5 mg/ml doxycyclin for 8 days prior to trans-
fection, and maintained in selection media for the
duration of experiments.
GFP quantiﬁcation
peGFP-Mirt transfected HEK-293 cells were lysed at 48 h
post-transfection and protein content determined using
the micro BCA protein assay (Pierce Biotechnology,
USA). Fifty microgram of protein was assayed for GFP
ﬂuorescence using a plate reader. Background ﬂuores-
cence determined from cells transfected with target alone
was subtracted.
RT–PCR and RT-qPCR
peGFP-Mirt transfected HEK-293 cells were lysed at 48 h
post-transfection and RNA harvested using the Trizol
protocol (Invitrogen, USA). Reverse transcription was
performed on 500 ng of RQ1 DNase treated (Promega,
USA) RNA using an expand reverse-transcriptase kit
(Roche, UK) and sequence speciﬁc reverse primer. PCR
reactions were performed using primers ﬂanking the
intronic region inserted into GFP (50-TCTTCAAGTCC
GCCATGCC-30 and 50-TGTCGCCCTCGAACTTCA
C-30). PCR products were visualized on a 3% agarose
gel. For real-time PCR of target mRNAs, 1 mg of total
RNA was reverse transcribed with random hexamers using
the Precision Reverse Transcription kit (PrimerDesign,
UK) as per manufacturer’s instructions. Realtime PCR
was performed with 25 ng of cDNA using Precision
Mastermix (PrimerDesign, UK). For small RNA qPCR,
10 ng of total RNA was reverse transcribed with
sequence-speciﬁc stem–loop primers and the Taqman
miRNA Reverse Transcription kit (Applied Biosystems,
USA) according to manufactures protocol. Realtime
PCR was performed on 1 ng of cDNA using Taqman
Universal PCR Master Mix and custom Taqman probes
(Applied Biosystems, USA).
RNAi pathway saturation
Saturation of Exportin-5 and Dicer was carried out as
previously reported using adenoviral associated RNA 1
(VA1) (10) using the pAdVantage vector (Promega,
USA) expressing both VA1 and VA2. Luciferase targets
and respective shRNA/mirtron constructs were trans-
fected each at a constant concentration of 500 ng/ml and
luciferase assays performed 48 h post-transfection.
Concentrations of pAdVantage were subsequently varied
from 0 to 2 mg/ml in individual experiments, with the total
DNA transfected maintained constant at 3 mg/ml by co-
transfection with a stuffer plasmid at appropriate concen-
trations. Results are normalized to the luciferase ratio
determined for the non-targeting control construct for
each individual experiment in the absence of pAdVantage.
Northerns/small RNA detection
Thirty micrograms of total RNA extracted from HEK-293
cells 48 h post-transfection was resolved on urea
denaturing 15% polyacrylamide gels and blotted onto
nylon membranes. Decade Marker (Ambion, USA) was
prepared according the manufacturer’s instructions and
run alongside the cellular RNA. Blots were hybridized
to DNA oligonucleotides complementary to regions
spanning the target antisense sequences of the hairpins.
Probes were labelled at their 50-ends using [g-32P] ATP
with T4 Polynucleotide kinase then puriﬁed using
standard procedures. Analysis was carried out using a
FLA-7000 phosphorimager (Fujiﬁlm, Japan).
Oligonucleotide sequences used as probes were:
mir-877—50 CCCCTGCGCCATCTCCTCTAC;
miR-1224—50 CTCCACCTCCCCAGTCCTCAC.
To perform 30-rapid ampliﬁcation of cDNA ends
(RACE) of miR-877 mature species, 1 mg of total RNA
was poly-A tailed and reverse-transcribed with the NCode
Vilo miRNA cDNA synthesis kit (Invitrogen, USA) as per
manufacturer’s instructions. cDNA products were subject
to PCR using a universal reverse primer and miR-877
speciﬁc forward primer (50 GTAGAGGAGATGGCGC
AGG 30). Product were visualized on a 3% agarose gel
and additionally TA cloned into the pGem T-Easy
vector (Promega, UK), transformed and individual
colonies sequenced (Geneservice, UK).
High-throughput sequencing
HEK cells were grown in 24-well plates to 80% conﬂuence
and transfected with 500 ng of each mirtron. Small RNA
libraries were prepared with the ‘Small RNA v1.5 Sample
Prep Kit’ following the manufacturer’s instructions
(Illumina). Brieﬂy, total RNA was isolated from each
transfection by Trizol extraction and pooled. The RNA
was ligated with 30 RNA adaptor modiﬁed to target small
RNAs with 30 hydroxyl groups, and then with 50 RNA
adaptor. Reverse transcription followed by PCR was per-
formed to select for adapter ligated fragments and
double-stranded DNA libraries were size selected by
PAGE puriﬁcation (6% TBE PAGE). Libraries were
sequenced on a Genome Analyzer IIx for 36 cycles follow-
ing manufacturer’s protocols. The image analysis and base
calling were done using Illumina’s GA Pipeline. Adapters
were trimmed with Biopieces remove_adapter script and
remaining sequences were aligned against full-length
mirtron hairpins.
Western blotting
Cells were lysed at 48 h post-transfection, protein content
determined using the micro BCA protein assay (Pierce
Biotechnology, USA), and 25 mg run on 10% SDS–
PAGE gels. For Drosha western detection, blots were
probed with a rabbit polyclonal antibody to Drosha at a
1:1000 dilution. Blots were stripped and re-probed with
mouse monoclonal to GAPDH at 1:20 000. Goat
anti-rabbit secondary antibodies (Chemicon, USA) were
used at a 1:10 000 dilution, and goat anti-mouse secondary
at 1:10 000. All antibodies were purchased from Abcam
(Abcam, USA) unless otherwise stated.
Statistical analysis
Statistical signiﬁcance between control and experimental
values was determined using Student’s t-test (paired, two
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tailed). All data are expressed as means SD unless other-
wise stated.
RESULTS
miR-877, miR-1224 and miR-1226 are functional
mammalian introns
To test whether predicted mammalian mirtrons are func-
tional introns, the 86 nt human sequence of the conserved
mammalian miRNA, miR-877, the 85 nt murine sequence
of the conserved miRNA, miR-1224 or the 75 nt sequence
of the primate-speciﬁc miRNA, miR-1226, were placed
into a modiﬁed expression plasmid, peGFP-Mirt, as
introns within the eGFP open reading frame (ORF;
Figure 1A and Supplementary Figure S1). Variants of
the putative mirtron sequences of miR-877 (mirt-miR-
877), miR-1224 (mirt-miR-1224) and miR-1226 were
generated in which mutations were made to key regulatory
sequences required for splicing (Figure 1B and
Supplementary Figure S1). These included changes to
the predicted branch point sequence within a CAGAC
motif in the loop region of miR-877 (mirt-miR-877BP),
and changes to one or both of the invariant splice site
recognition sequences at the 50- or 30-ends of the intron
for all miRNAs (mirt-miR-877US, mirt-miR-877DUS, mirt-
miR-1224DUS, mirt-miR-1226US). Although, attempts
were made to identify the branch-point of miR-1224 and
miR-1226 by making constructs with changes at putative
branch point sequences, none of these mutations abol-
ished splicing and were omitted for these putative
mirtrons. The branch point is indispensible for the splicing
reaction and an A residue acts as the site of 20–50 diester
linkage in formation of intermediate branched lariats (11).
The terminal 50 splice site recognition sequence of GU and
the 30 splice-site recognition sequence of AG are highly
conserved across introns such that changes to either of
these regions is likely to interfere with splice junction de-
termination (11). A ﬁnal construct was generated in which
the predicted mature sequence of miR-877 was scrambled
(mirt-miR-877Scr) (Figure 1B)
Expression of mirt-miR-877, mirt-miR-1224 and
mirt-miR-1226 in HEK-293 cells resulted in eGFP ﬂuor-
escence, which is indicative for successful splicing, as did
incorporation into the peGFP-Mirt vector of a compar-
able length (91 nt) control derived from NADH-coenzyme
Q reductase intron 6 (NAD intron) which lacks
hairpin-forming potential (Figure 1C and Supplementary
Figure S1). Whereas mirt-miR-877Scr also spliced success-
fully, mutations made in mirt-miR-877BP, mirt-miR-
877US and mirt-miR-877DUS abrogated eGFP ﬂuores-
cence. Quantiﬁcation of eGFP shows that ﬂuorescence
levels generated by mirt-miR-877 and mirt-miR-877Scr
were 21% and 60% of the NAD intron, respectively
(Figure 1D), indicating that miR-877 is less efﬁcient as
an intron compared to the NAD intron and implying
that sequence changes in mirt-miR-877Scr improve splic-
ing efﬁciency. The incomplete splicing of mirt-miR-877 in
this system could represent a consequence of placing this
intron outside of its natural sequence context, or alterna-
tively it may reﬂect a recent evolution of this sequence as
A
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Figure 1. miR-877 and miR-1224 are functional mammalian introns.
(A) Putative mirtrons were studied by inserting appropriate sequences
as introns within an eGFP transcript. (B) Predicted mirtron alignments
for miR-877 and miR-1224 sequences incorporated into the pMirt
vector. Variants with modiﬁcations made to splicing regulatory se-
quences are indicated by dashed boxes. US=unspliceable,
DUS=double unspliceable, BP=Branch-point, Scr=Scrambled.
Blue and red nucleotides represent the guide sequence and modiﬁed
nucleotides, respectively. (C) Representative ﬂuorescent microscopy
images of different mirt-miR-877 and mirt-miR-1224 variants 48 h
after transfection in HEK-293 cells. NAD represents a control intron
of comparable length to miR-877 and miR-1224 with no
hairpin-forming potential. (D) Upper panel—Quantiﬁcation of eGFP
ﬂuorescence following expression of mirt-miR-877 and mirt-miR-1224
variants in HEK-293 cells. Values represent mean ﬂuorescent SD
from n=3. *P< 0.05 relative to non-transfected cells. Lower panel—
RT–PCR with intron-spanning primers following expression of
miR-877 and miR-1224 variants in HEK-293 cells.
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an intron. Mirt-miR-1224 was also splicing-competent
and successfully produced 78% of the ﬂuorescence of
the control NAD intron, while mutations made to the
50- and 30-splice sites in mirt-miR-1224DUS resulted in
no detectable eGFP ﬂuorescence (Figure 1C and D).
This suggests miR-1224 was more efﬁcient as an intron
than miR-877, perhaps because of a longer poly-
pyrimidine tract in its 30 arm which is necessary for
proper splicing. Lastly, mirt-miR-1226 spliced to 45% of
the level of the NAD intron, and this was abrogated by 50
splice site mutations in mirt-miR-1226US (Supplementary
Figure S1).
To demonstrate that eGFP ﬂuorescence correlates with
intron removal, RT–PCR was performed using intron-
spanning primers on total RNA from cells transfected with
mirt-miR-877 and mirt-miR-1224 variants (Figure 1D).
The ratio of un-spliced to spliced transcripts, represented
by large and small transcripts, respectively, conﬁrms
results seen with eGFP quantiﬁcation. More un-spliced
transcript was produced compared to spliced transcript
for mirt-miR-877 (63% versus 37%, respectively), and
less un-spliced transcript was produced than spliced tran-
script for mirt-miR-877Scr (37% versus 63%, respect-
ively). In contrast, no spliced transcript was observed in
eGFP-negative variants of mirt-miR-877. The enhanced
eGFP production of mirt-miR-1224 relative to mirt-
miR-877 was also seen with RT-PCR, with near complete
(88%) spliced transcript produced for mirt-miR-1224
(Figure 1D). Together the results demonstrate that
miR-877 and miR-1224 possess necessary sequence con-
straints to be spliced from a co-expressed mRNA
transcript.
miR-877, miR-1224 and miR-1226 are splicing-dependent
mammalian mirtrons
The miRNA derived from the 50-arm of miR-877 is en-
riched in small RNA libraries compared to that derived
from the 30-arm, suggesting that the 50-arm harbours the
dominant miRNA species (4). Similarly, the 50-arm of
miR-1224 produces the dominant species in small RNA
libraries (4,12). In contrast the 30-arm of miR-1226 is
expected to be processed into the dominant miRNA
species (4). Thus, fully complementary targets to the
50-arm of both miR-877 and miR-1224, and the 30-arm
of miR-1226 were inserted in the 30-UTR of Renilla
luciferase gene in a dual-luciferase reporter vector. Ratios
of Renilla luciferase to constitutively expressed Fireﬂy
luciferase were used to assess knockdown efﬁciency.
Expression of mirt-miR-877 alongside its target resulted
in knockdown of 60% (P=0.001), while this silencing
effect was abolished by splicing-deﬁcient mutants
(Figure 2A). This implies that silencing had been achieved
with mirt-miR-877 in a splicing-dependent manner. To
eliminate the possibility that the mutations introduced
into splicing-deﬁcient variants directly affected knock-
down of the target, U6-driven pre-miRNA controls were
made, which corresponded to the sequences of putatively
spliced mirtron variants. Expression of each variant along-
side the miR-877 target sequence demonstrated no effect
on the silencing ability relative to the respective wild-type
pre-miRNA control. This was despite single nucleotide
mismatches to the miR-877 target sequence at the 50-end
of pre-miR-877US and pre-miR-877DUS guide strands,
and minor weakening of the predicted pre-miRNA
hairpins of each variant (Figure 2A). This conﬁrmed
that the introduced mutations abrogated silencing by
A
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Figure 2. miR-877 and miR-1224 are splicing-dependent mammalian
mirtrons processed into small RNA species. (A) Dual-luciferase
reporter assays showing knockdown of a complementary miR-877
target or miR-1224 target following co-transfection with indicated
mirtron (dark bars) and pre-miRNA control (light bars) variants.
Values represent mean ratios of Renilla: Fireﬂy luciferase SD from
n=6. Mirtron variants are normalized to cells transfected with the
NAD variant. Pre-miRNA variants are normalized to cells transfected
with a non-speciﬁc U6 pre-miRNA hairpin. *P< 0.05 relative to re-
spective normalizing control. (B) Upper panel—30 RACE RT–PCR of
total RNA from HEK-293 cells transfected with NAD construct or
mirtron/pre-miRNA variants of miR-877 using a miR-877 speciﬁc
forward primer. Lower panel—Sequencing of 30 RACE RT-PCR
products identiﬁes Dicer cleavage sites. (C) 18–25 nt small RNAs
were extracted by polyacrylamide gel isolation from total RNA of
HEK cells transfected with equimolar amounts of miR-877 and
miR-1224 each as introns within separate eGFP mRNAs. Linkers
were added to both ends of the RNA for RT–PCR ampliﬁcation
before deep sequencing using an Illumina Genome Analyzer.
Sequences highly matched to any part of miR-877 or miR-1224
hairpin were identiﬁed and the incidence of each nucleotide in the
sequenced small RNAs was plotted against miR-877 or miR-1224
sequences.
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inhibiting splicing rather than by producing pre-miRNA
substrates that inefﬁciently enter downstream RNAi
events. Reduced levels of silencing were seen with both
mirtron and pre-miRNA scrambled constructs when com-
pared to wild-type constructs, thus conﬁrming that knock-
down by mirt-miR-877 was a sequence-speciﬁc effect
(Figure 2A). A target complementary to the 30-arm of
miR-877 was not silenced by any construct, which corrob-
orates deep sequencing data that the 50-arm miRNA of
miR-877 is preferentially selected (Supplementary Figure
S2). Collectively, these data are consistent with miR-877
acting as a splicing-dependent RNAi effector which
derives an antisense species from its 50-arm, and imply
that miR-877 has mirtron origins.
Mirt-miR-1224 and mirt-miR-1226 also silenced corres-
ponding dual-luciferase targets by 87% (P< 0.001) and
35% (P=0.002), respectively, with silencing inhibited in
both cases by mutations made to splice sites (Figure 2A
and Supplementary Figure S1). The weak silencing by the
mirt-miR-1224DUS mutant is likely to be an artefact
rather than a Drosha-dependent effect (Figure 2A).
Silencing by miR-1224 and miR-1226 pre-miRNA
variants subsequently conﬁrmed that mutations affect
splicing rather than silencing efﬁciency of the antisense
species (Figure 2A and Supplementary Figure S1), and
collectively the data veriﬁes the splicing-dependent mirtron
origins of both miR-1224 and miR-1226. In addition,
silencing by mirt-miR-1224 was equal to that of the
equivalent pre-miR-1224 control (Figure 2A). This
shows that mirtrons can silence as effectively as independ-
ent pre-miRNA precursors, and this result may have im-
plications for development of synthetic mirtrons.
miR-877 is processed to small RNA species that
correspond to the predicted guide strand
To conﬁrm that RNAi was responsible for the silencing
effect of these mirtrons, we sought to detect processed
small RNA species of mirt-miR-877 and mirt-miR-1224
pre-miRNA and mirtron variants with northern blots
using standard or locked nucleic acids (LNA)-based
probes. The mature miRNA species could not be detected
for any of these constructs while pre-miRNA precursors
could be detected for all constructs except mirt-miR-877.
This suggests that the hairpin processed from mirt-miR-
877 is in low abundance and escapes detection. This is
likely since precursors of the pre-miR-877 control were de-
tected (Supplementary Figure S3). Interestingly, however,
the processed pre-miRNA species detected for the
mirt-miR-1224 variant was expressed 22.5-fold lower
than the pre-miR-1224 control despite comparable levels
of silencing (Supplementary Figure S3). Mirtrons there-
fore appear capable of directing comparable levels of
silencing to a U6-expressed pre-miRNA, despite much
weaker levels of precursor expression. This could be indi-
cative of a controlling step in mirtron biogenesis which
may act to limit the accumulation of potentially toxic
pre-miRNA-like hairpins in the cell in a manner equiva-
lent to that seen in Drosha processing of pri-miRNAs
(13,14).
An alternative 30-RACE approach was devised to detect
mirt-miR-877 small RNA species in which a poly-A tailing
and ﬁrst strand-synthesis step was followed by PCR with a
mature miR-877 sequence-speciﬁc primer and a universal
primer. Bands of expected size were detected for both
mirt-miR-877 and pre-miR-877, but not for the NAD
intron and mirt-miR-877DUS (Figure 2B). The miR-877
speciﬁc forward primer was designed to reveal precise
position of Dicer cleavage by extension through the
guide strand/polyA junction. Cloning and sequencing of
the products revealed sequences corresponding to the pre-
dicted miR-877 mature sequence for both mirtron and
pre-miRNA control variants (Figure 2B). The results
conﬁrm that small RNA species are being processed and
generated from miR-877 precursor constructs of mirtron
origin.
Finally, deep sequencing following enrichment of small
RNA species was performed in HEK-293 cells transfected
with mirt-miR-877, mirt-miR-1224 and mirt-miR-1226.
Sequence reads corresponding to the predicted mature
species of each mirtron were detected (Figure 2C and
Supplementary Figure S1). Interestingly, despite similar
amounts of each construct being transfected in each ex-
periment, it can be seen that miR-1226 displays a much
lower number of read counts, likely indicating inefﬁcient
processing from this construct and potentially explaining
its poor silencing ability. When taken together with the
results in Figure 2A, the data conﬁrm that miR-877,
miR-1224 and miR-1226 are splicing-competent mirtrons
capable of complementary target silencing in an RNAi-
like manner.
Mammalian mirtrons are Drosha independent
To examine the role of Drosha in mirtron-mediated
RNAi, HEK-293 cells were transduced with a lentivirus
containing a Drosha-targeting shRNA (15), resulting in
reduced Drosha expression by 66% relative to cells
stably expressing a non-speciﬁc shRNA (Figure 3A). To
ﬁrst conﬁrm that Drosha knockdown affected miRNA
processing, pri-miR-30 and pri-miR-122 mimics were
transfected with corresponding luciferase targets. Both
pri-miR-30 mimics containing a-synuclein targeting guide
strands and a miR-122 mimic containing an HBV target-
ing guide strand (8) showed signiﬁcantly reduced levels of
silencing of their respective fully complementary luciferase
targets when the Drosha shRNA was expressed relative
to the control shRNA (Figure 3B and Supplementary
Figure S4). However, the de-repression of silencing by
pri-miR-122/HBV and both a-synuclein pri-miR-30
mimics was not complete, indicating the presence of
residual amounts of Drosha activity.
We next looked at the effects of Drosha silencing on
miR-877 activity. As a separate Drosha-dependent
control, we generated a pri-miR-30 mimic embedded with
miR-877 guide sequence (pri-miR-30/877). Following
shRNA-mediated silencing of Drosha, both the mirt-
miR-877 construct and pre-miR-877 control retained the
ability to silence the luciferase target to the same levels as
those shown in the non-speciﬁc shRNA-expressing cells.
In contrast, the pri-miR-30/877 construct presented
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signiﬁcantly reduced expression of the target (Figure 3C),
with residual Drosha levels likely accounting for incom-
plete de-repression. The additional mirtrons, miR-1226
and miR-1224, were likewise unaffected by Drosha
knockdown (Supplementary Figure S4).
Finally, silencing by mirt-miR-877 was unaffected by
co-expression of a dominant negative Drosha construct
(Tn Drosha) with mutations made to both RNase III
domains (9). In contrast, silencing by the pri-miR-30/877
construct was signiﬁcantly reduced from 86% to 69%
(P< 0.001) (Supplementary Figure S4). It is clear that
the unchanged silencing activity of mirt-miR-877 in both
of these assays indicates that entry into the RNAi pathway
by mammalian mirtrons is below the level of Drosha pro-
cessing, corroborating the results associated with mirtrons
in D. melanogaster (1).
Mammalian mirtrons have variable dependence on the
canonical RNAi pathway downstream of Drosha
In invertebrates, the predicted alignments of mirtron
pre-miRNA hairpins result in 2 nt overhangs at the
30-end of mirtrons. This follows both the consensus
termini preference of Drosha processing and the recogni-
tion signals for exportin-5-mediated export and Dicer
binding (3,16,17). In contrast, most predicted mammalian
mirtron alignments exhibit atypical overhangs at the base
of the stem (4). Examples include single nucleotide
overhangs at both the 50- and 30-ends (miR-1224), and
3 nt 50 overhangs together with 2 nt 30 overhangs
(miR-1226). As such, it is unclear to what extent
putative mammalian mirtrons are dependent on RNAi
pathway elements following pre-miRNA formation.
In order to determine the dependence of mammalian
mirtrons on processing steps downstream of Drosha
cleavage, we saturated the canonical pathway using adeno-
viral associated RNA (VA1), a substrate for both
Exportin-5 and Dicer (10). As expected, expression of
competing VA1 successfully led to reduced silencing of
the miR-877 target by the pre-miR-877 control in a con-
centration-dependent manner (Figure 4A). Transfection
alongside mirt-miR-877 likewise leads to de-repression of
the miR-877 target, suggesting that miR-877 mirtron is
likely to be dependent on both Exportin-5 and Dicer
(Figure 4B) and furthermore that the identity of
Exportin-5 substrates may be less constrained than previ-
ously thought. Indeed, exogenous addition of Exportin-5
rescued the silencing ability of mirt-miR-877 in the pres-
ence of VA1, which suggests that at least part of the VA1
abrogation of silencing was due to reduced Exportin-5
availability (Supplementary Figure S5). It is expected
that the increased silencing by mirt-miR-877 in the
presence of Exportin-5 and VA1 relative to Exportin-5
alone is a result of VA1s ability to enhance transient protein
expression leading to increased Exportin-5 availability (18).
A C
B
Figure 3. Mammalian mirtrons are Drosha independent. (A) Western blotting of protein lysates following transduction of HEK-293 cells with
lentivirus expressing a non-speciﬁc control shRNA or Drosha targeting shRNA. (B) Dual-luciferase reporter assay showing knockdown of a HBV
target sequence following co-transfection with an HBV-targeting pri-miR-122 mimic in the presence of a non-speciﬁc shRNA or Drosha-targeting
shRNA. Values represent mean ratios of Renilla: Fireﬂy luciferase SD from n=6. Values are normalized to cells transfected with a non-speciﬁc
pri-miR-122 mimic in the presence of the respective shRNA construct.*P< 0.05 relative to respective normalizing control. (C) Dual-luciferase
reporter assay showing knockdown of a miR-877 target sequence following co-transfection with indicated mirt-miR-877, pre-miR-877 or miR-877
pri-miR-30 mimic in the presence of a non-speciﬁc shRNA or Drosha-targeting shRNA. Values represent mean ratios of Renilla: Fireﬂy luciferase
SD from n=6. Mirtron variants are normalized to cells transfected with the NAD variant. Pre-miRNA variants are normalized to cells transfected
with a non-speciﬁc U6 pre-miRNA hairpin. Pri-miRNA-30 mimics are normalized to cells transfected with a non-speciﬁc pri-miR-30 mimic.
*P< 0.05 relative to respective normalizing control.
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In contrast, attempts to saturate both pre-miR-1224 and
mirt-miR-1224 variants with VA1 were unsuccessful
(Figure 4C and D) and expression of exogenous
Exportin-5 (Supplementary Figure S5) does not increase
mirt-miR-1224 knockdown either. Both variants have
single nucleotide overhangs at both the 50- and 30-ends
of the hairpin and it is possible that this structural motif
is not favoured by Exportin-5 and/or Dicer binding. In the
presence of very high concentrations of Exportin-5,
brought about by VA-1 expression, competition with ca-
nonical targets of Exportin-5 is reduced and miR-1224 can
be a substrate for Exportin-5, leading to increased
silencing (95%) (Supplementary Figure S5).
miR-877 silences the predicted seed-matched target FXR2
in neuronal SH-SY5Y cells
We next sought conﬁrmation that mirtrons are physiolo-
gically relevant mammalian miRNAs. Microarray data
indicates that the ATP-binding cassette subfamily F
member 1 (ABCF1) transcript, within which miR-877 is
the 13th intron, is expressed in the human dopaminergic
SH-SY5Y cell line (19). Likewise, miRNA expression
proﬁling implies that miR-877 is expressed in this cell
line, albeit at low levels (1.1% of all miRNA species)
(20). The expression of miR-877 in a neuronal cell line
such as SH-SY5Y supports previous predictions that this
is a primate-speciﬁc mirtron identiﬁed in small RNA
libraries from brain tissue (4). We therefore identiﬁed
nine high-scoring putative 30-UTR targets of miR-877
using two miRNA target prediction algorithms (seven
from targetscan, two from miranda), which were add-
itionally expected to be expressed in this cell line
(Supplementary Table S2). Short luciferase targets corres-
ponding to the strongest predicted miR-877 30-UTR target
sites for each of these genes where generated and expressed
alongside either mirt-miR-877 or the pre-miR-877 control
in HEK-293 cells. Normalization to non-speciﬁc control
constructs demonstrated that six of these targets were
silenced in response to mirt-miR-877 and pre-miR-877
despite highly similar seed sequences across all targets
(Figure 5A). These data imply that miR-877, like canon-
ical miRNAs, is able to silence imperfectly matched target
sequences with extensive base pairing across the seed
region, while some of the identiﬁed target sequences may
not be functional miR-877 target sites although this
remains to be conﬁrmed.
In order to conﬁrm SH-SY5Y cells as a model cell line
to study miR-877, RT–PCR and sequencing were ﬁrst
used to conﬁrm removal of intron 13 in the ABCF1
mRNA transcript (Supplementary Figure S6). Guide
strands of processed miR-877 were subsequently detected
with qPCR in SH-SY5Y cell total RNA extract. However
the miR-877 guide strand was in low abundance relative to
both the small nucleolar RNA, RNU-24 and miR-16,
which is in agreement with previous deep-sequencing data
(Figure 5B and Supplementary Figure S6). Transfection of
either a miR-877 targeting antagomir or a miR-877
sponge bearing seven sequential FXR2 target sequences
driven off a U6 promoter were initially used to determine
if de-repression of the FXR2 target could be detected. No
change in protein or mRNA levels was seen and it is
possible that the miRNA are too low in this cell line for
any interaction to be detected. Recently, it was shown that
84% of miRNA targets demonstrate reductions in
mRNA levels in the presence of the targeting miRNA
(21). Therefore, to determine if this is true for miR-877
targets, mirt-miR-877 or the control NAD intron were
overexpressed in SH-SY5Y cells. At 96 h post-transfection
A B
DC
Figure 4. Mammalian mirtrons have variable dependence on the ca-
nonical RNAi pathway following pre-miRNA formation. (A and B)
Dual-luciferase reporter assay showing knockdown of a miR-877
target sequence following co-transfection with indicated pre-miR-877
variants (A) or mirt-miR-877 variants (B) in the presence of increasing
concentrations of VA1 expressed from the pAdvantage vector. Values
represent mean ratios of Renilla: Fireﬂy luciferase SD from n=6.
Pre-miRNA variants (A) are normalized to cells transfected with a
non-speciﬁc U6 pre-miRNA hairpin and no pAdvantage vector.
Mirtron variants (B) are normalized to cells transfected with
mirt-miR-877DUS and no pAdvantage vector. (C and D) Dual-
luciferase reporter assay showing knockdown of a miR-1224 target
sequence following co-transfection with indicated pre-miR-1224
variants (C) or mirt-miR-1224 variants (D) in the presence of increasing
concentrations of VA1 expressed from the pAdvantage vector. Values
represent mean ratios of Renilla: Fireﬂy luciferase SD from n=6.
Pre-miRNA variants (C) are normalized to cells transfected with a
non-speciﬁc U6 pre-miRNA hairpin and no pAdVantage vector.
Mirtron variants (D) are normalized to cells transfected with
mirt-miR-1224DUS and no pAdVantage vector.
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qPCR revealed a 4.8-fold increase in miR-877 guide strand
abundance when mirt-miR-877 was expressed relative to
endogenous levels in the presence of the NAD intron
(Figure 5B and Supplementary Figure S6). This change
was lower than expected given the strong promoter, high
transfection efﬁciency and extensive eGFP ﬂuorescence
seen. However, the data are in agreement with northern
blots that low levels of miR-877 are processed from this
construct. At this time point the transcript levels of FXR2
and other predicted miR-877 targets identiﬁed in
luciferase assays were determined by qPCR. A signiﬁcant
19% reduction (P< 0.001) in relative expression of the
FXR2 transcript was detected in the presence of
overexpressed mirt-miR-877 relative to the NAD intron,
whereas additional targets failed to show any signiﬁcant
reduction (Figure 5C). This level of FXR2 target knock-
down was additionally conﬁrmed following transfection
with the pre-miR-877 control construct (Supplementary
Figure S7). Attempts to detect reduction of FXR2
protein levels by western blot were unsuccessful in transi-
ent transfection experiments, suggesting either a long
half-life for this protein FXR2, or that more robust inhib-
ition, perhaps with other miRNAs in conjunction, may be
needed to induce functional knockdown. However, col-
lectively the data conﬁrms that an anti-sense species
derived from miR-877 functionally interacts and is able
to reduce mRNA transcripts of FXR2, but further
characterization is needed to conﬁrm FXR2 as an en-
dogenous target of this mirtron.
DISCUSSION
Canonical mammalian miRNA biogenesis initially in-
volves processing of long primary-miRNA transcripts by
a microprocessor complex (3), yet recent evidence has
demonstrated alternative methods of mature miRNA gen-
eration (1,22,23). Here, we have experimentally evaluated
the mirtron origins of three mammalian miRNAs;
miR-877, miR-1224 and miR-1226. We have shown these
to be a class of splicing-dependent, microprocessor-
independent species by using an eGFP model to assess
splicing ability and inhibition of RNAi-pathway elements.
These data corroborate the conﬁrmed mirtron origin of
miRNAs identiﬁed and demonstrated in C. elegans and
D. melanogaster (1,2). Interestingly, we show that mirtrons
have a variable dependence on Exportin-5 and/or Dicer
after forming a pre-miRNA-like hairpin, with miR-1224
unaffected by a competitive inhibitor of downstream
RNAi pathway elements. Lastly, we show that seed-
matched targets can be silenced by miR-877 in a similar
manner to canonical miRNAs, and that mRNA-encoding
FXR2, an RNA-binding protein that acts as a regulator of
translation (24), can be reduced by miR-877 in the
neuronal SH-SY5Y cell line.
Splicing-dependence was conﬁrmed for mirtron precur-
sors of miR-877, miR-1224 and miR-1226 by showing that
changes to regulatory splicing motifs present in these
hairpins could abrogate splicing, while the silencing
ability of putatively spliced U6-transcribed pre-miRNA
A
B C
Figure 5. miR-877 silences the predicted seed-matched target FXR2 in neuronal SH-SY5Y cells. (A) Dual-luciferase reporter assay showing
knockdown of predicted miR-877 target sequences following co-transfection with indicated mirt-miR-877 or pre-miR-877 variants. Values represent
mean ratios of Renilla: Fireﬂy luciferase SD from n=3. For each unique target, mirtron variants are normalized to cells transfected the NAD
variant and pre-miRNA variants are normalized to cells transfected with a non-speciﬁc U6 pre-miRNA hairpin. *P< 0.05 relative to respective
normalizing control. (B) qPCR detection of miR-877 in SH-SY5Y cells in the presence or absence of mirt-miR-877. Values represent relative miR-877
expression normalized to RNU-24 expression using the 2Ct method and n=6. (C) Relative expression of putative miR-877 target transcripts
determined with RT–qPCR following transfection of SH-SY5Y cells with the NAD variant or mirt-miR-877. Values represent mean expression
relative to b-actin expression SD using relative standard curve method and n=6. Transcript levels in presence of mirt-mir-877 are normalized to
cells transfected with the NAD variant.
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equivalents was unaffected. Interestingly, small-RNA
hybridization experiments point to low or un-detectable
levels of splicing-dependent pre-miRNA precursors for
miR-877 and miR-1224. This is despite high levels of
host transcript expression and comparable levels of
silencing to U6-transcribed pre-miRNA controls that
were shown to be expressed in relative abundance.
Similarly, qRT–PCR conﬁrmed that low levels of en-
dogenous miR-877 guide strands are present in
SH-SY5Y cells, and further that ectopic mirt-miR-877 ex-
pression had only a modest effect on mature miR-877
guide strand levels despite substantial eGFP host tran-
script expression. Together this suggests mirtron biogen-
esis could be regulated during splicing to limit
accumulation of RNAi precursors, a feature which may
have functional signiﬁcance in protecting cells from satur-
ation of the miRNA pathway (13,14). Further, failure to
pick up processed guide strands in the small-RNA
hybridization experiments, despite precursor detection of
U6-transcribed pre-miRNA controls, points towards inef-
ﬁcient processing of these hairpins and may reﬂect a more
recent evolutionary history than canonical miRNAs.
All three mirtrons were additionally unaffected by
Drosha knockdown, while reduced silencing ability for
both pri-miR-30 and pri-miR-122 mimics demonstrates
Drosha dependence of these miRNAs. It is known that
the miRNA pathway can be overloaded (13) with
Drosha processing appearing to be a rate-limiting step
(14). In this regard, it is tempting to speculate that a
higher capacity biological processing system other than
microprocessor activity could have become a necessity
for certain miRNAs with crucial roles in development or
normal physiology (5). Alternatively, the speciﬁc recogni-
tion signals for microprocessor processing may be prohibi-
tive for new miRNAs to have evolved from intronic
sequences, while the mirtron pathway offers a less con-
strained route for short introns to have rapidly evolved
into miRNAs. Indeed, this is supported by restriction of
all reported mirtrons to either distinct invertebrate or
mammalian orders, in contrast, to several canonical
miRNAs that show more extensive species conservation
(4,25). This may additionally explain the apparent
reduced dependence of miR-1224 on downstream RNAi
processing elements that were shown by saturation of both
Exportin-5 and Dicer with a viral inhibitor of both these
proteins (10).
Lastly, FXR2 has been identiﬁed as a possible target of
miR-877 in a neuronal cell model. Speciﬁcally, a reduction
in FXR2 mRNA expression levels was seen when a
4.8-fold increase in miR-877 guide strand was induced
by ectopic expression of miR-877, although a reduction
in FXR2 remains to be conﬁrmed at the protein level to in
order to validate this as a target for miR-877. FXR2 is an
RNA-binding protein which has functional overlap as a
regulator of translation with the Fragile-X mental retard-
ation 1 (FMR1) gene that is mutated or absent in FMR
(24,26). Meanwhile, the ABCF1 gene that hosts the
miR-877 intron has been shown to have a role in the ini-
tiation of translation through interactions with eukaryotic
initiation factor 2 (27), potentially placing it in the same
biological pathway as FXR2. Further conﬁrmation will be
required of this mirtron: target interaction in future
through other methods which block the endogenous
miRNAs activity. To date, this has been hampered by in-
effective blockade of miR-877 activity using both a U6
transcribed sponge sequence and a chemically stabilized
antagomir which target the silencing ability of miR-877.
However, this may be achievable in future through the use
of steric block antisense oligonucleotides to block the bio-
genesis of miR-877 at the level of splicing (28).
In summary, the work presented here provides experi-
mental veriﬁcation for the existence of splicing-dependent
miRNAs within the mammalian genome. This raises ques-
tions for future research regarding the function of this
pathway, the regulation of miRNAs generated via
splicing, and whether the expression of human mirtrons,
which presently represent 1–2% of all annotated human
miRNAs (13/940), are differentially expressed in certain
pathologies as seen with canonical miRNAs (29).
Unfortunately, the study of mirtrons is likely to be
hampered by the low abundance of mirtron transcripts
as identiﬁed by deep sequencing (4) and our work.
However, the development of artiﬁcial mirtron expression
systems may be able to shed more light on the endogenous
function of these mirtrons. Finally, splicing-dependent
biogenesis represents a novel entry point into the RNAi
pathway that could be exploited synthetically with poten-
tial advantages including Drosha independence and tight
regulation of mature miRNA species generation.
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